Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, September 1998, p. 2326-2331, Vol. 42, No. 9
Albany Medical College, Albany, New York
122081;
Rush Presbyterian St. Luke's
Medical Center, Chicago, Illinois
60612-38332;
University of Texas Medical
Branch, Galveston, Texas 77555-08353;
Northwestern University Children's Memorial Hospital, Chicago,
Illinois 606144;
University of
Colorado Medical Center, Denver, Colorado
802625;
Newton, Massachusetts
026156;
National Institutes of Health,
Bethesda, Maryland 20892-76207; and
Beth Israel-Deaconess Medical Center, Boston, Massachusetts
02215-54008
Received 23 February 1998/Returned for modification 16 April
1998/Accepted 12 May 1998
Rapid, quantitative, and objective determination of the
susceptibilities of human cytomegalovirus (HCMV) clinical isolates to
ganciclovir has been assessed by an assay that uses a
fluorochrome-labeled monoclonal antibody to an HCMV immediate-early
antigen and flow cytometry. Analysis of the ganciclovir
susceptibilities of 25 phenotypically characterized clinical isolates
by flow cytometry demonstrated that the 50% inhibitory
concentrations (IC50s) of ganciclovir for 19 of the
isolates were between 1.14 and 6.66 µM, with a mean of 4.32 µM
(±1.93) (sensitive; IC50 less than 7 µM), the
IC50s for 2 isolates were 8.48 and 9.79 µM (partially resistant), and the IC50s for 4 isolates were greater than
96 µM (resistant). Comparative analysis of the drug
susceptibilities of these clinical isolates by the plaque
reduction assay gave IC50s of less than 6 µM, with a mean
of 2.88 µM (±1.40) for the 19 drug-sensitive isolates,
IC50s of 6 to 8 µM for the partially resistant isolates,
and IC50s of greater than 12 µM for the four resistant
clinical isolates. Comparison of the IC50s for the
drug-susceptible and partially resistant clinical isolates obtained by
the flow cytometry assay with the IC50s obtained by the
plaque reduction assay showed an acceptable correlation
(r2 = 0.473; P = 0.001),
suggesting that the flow cytometry assay could
substitute for the more labor-intensive, subjective, and time-consuming
plaque reduction assay.
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Rapid Ganciclovir Susceptibility Assay Using Flow
Cytometry for Human Cytomegalovirus Clinical Isolates
*
Corresponding author. Mailing address: Department of
Microbiology, Immunology, and Molecular Genetics, A-68, Albany Medical College, 47 New Scotland Ave., Albany, NY 12208. Phone: (518) 262-5174. Fax: (518) 262-5748; E-mail:
jim_mcsharry{at}ccgateway.amc.edu.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |